companydata.dkcompanydata.dk

Pharmovital ApS: Financial statements 2026

CVR: 27206506

Source: annual report 2026, Danish Business Authority

01/07/2025 – 30/06/2026

Pharmovital ApS (CVR 27206506) has filed annual accounts for 2026. In 2026, the company reported a gross profit of DKK 8,519,379 and a net result of DKK 4,924,772 compared with DKK 586,153 the year before. That is an increase of 258% compared with the year before. Equity in the 2026 report amounted to DKK 8,743,173. The solvency ratio was 45.7%. The company had 2 employees in the financial year.

Gross Profit
DKK 8,519,379
Profit/Loss
DKK 4,924,772
Equity
DKK 8,743,173
Total Assets
DKK 19,146,552
Employees
2

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2026-8.5M4.9M8.7M2
2025-2.4M586K3.8M2
2024-3M1.2M3.5M3
2023-2.9M1M2.6M3
2022-2.5M719K2.3M3

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like Pharmovital ApS

Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.

Try the lead list generator

Events in 2026

Pharmovital ApS updates contact informationMar 23, 2026

Contact info changed: new phone: 25328499, new email: [email protected] (March 23, 2026).

About Pharmovital ApS

Pharmovital ApS is a Danish company of the type Anpartsselskab based in Søborg, founded in 2003. The company is registered under the industry Engroshandel med andre fødevarer. The company was previously named GALLIVIT ApS and ApS KBIL 17 NR. 1578. The management consists of Kristian Krogh and Eskil Krogh. The company is owned by Eskro Holding ApS and Kr. Krogh Holding ApS. The company has 7 employees (2026). In 2026, the company reported a gross profit of DKK 8,519,379 and a net result of DKK 4,924,772 compared with DKK 586,153 the year before. Equity in the 2026 report amounted to DKK 8,743,173.

Source: annual report 2026, Danish Business Authority